Great work @justcurious. I can well agree with some of the more balanced optimism on display in this group - there is plenty to feel optimistic about - but these massive misrepresentations are really frustrating and misleading.
The other one is that Celgene have had an exclusive look at the assets under the rofr which would not have been afforded to any other partner from Aril 2015 to 2016. Not only is this misleading, it would also be a negative were it to be true. Would you really be happy if other partners had been "locked out" of discussions about certain assets by a company who just simply bought shares at the market rate and held them in escrow for a year? An rofr simply allows the holder to match any offer made by another 3rd party who has equal opportunity to view the asset(s) under the rofr, but for months we have been reading otherwise.
My view for what it's worth, page-18
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.210B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $5.796M | 5.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15990 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 48632 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |